Biomarkers of Response to Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with Chronic Lymphocytic Leukemia

被引:15
作者
Fraietta, Joseph A. [1 ]
Lacey, Simon F. [1 ]
Wilcox, Nicholas S.
Bedoya, Felipe [2 ]
Chen, Fang [1 ]
Orlando, Elena [3 ]
Brogdon, Jennifer L. [3 ]
Hwang, Wei-Ting [4 ]
Frey, Noelle [1 ]
Young, Regina M. [1 ]
Pequignot, Edward [1 ]
Ambrose, David E. [5 ]
Levine, Bruce L. [1 ]
Bitter, Hans [3 ]
Porter, David L. [1 ]
Xu, Jun
June, Carl H.
Melenhorst, Jan Joseph [1 ]
机构
[1] Univ Penn, Ctr Cellular Immunotherapies, Perelman Sch Med, Philadelphia, PA USA
[2] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA USA
[3] Novartis Inst Biomed Res, Cambridge, MA USA
[4] Univ Penn, Philadelphia, PA USA
[5] Univ Penn, Ctr Cellular Immunotherapies, Sch Med, Philadelphia, PA USA
关键词
D O I
10.1182/blood.V128.22.57.57
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
57
引用
收藏
页数:4
相关论文
empty
未找到相关数据